Why Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) Stock Should Not Be Taken For Granted By Investors In 2025
In the last trading session, 2.24 million shares of the Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) were traded, and its beta was 0.93. Most recently the company’s